跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
BRINZOLAMIDA/BRIMONIDINA ZENTIVA 10 MG/ML+2 MG/ML COLIRIO EN SUSPENSIÓN
Approved
STANDARD
BRINZOLAMIDA/BRIMONIDINA ZENTIVA 10 MG/ML+2 MG/ML COLIRIO EN SUSPENSIÓN
Zentiva K.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 18, 2024
Approval ID
e660d5414239d820
Company
Zentiva K.S.
Type
Standard
Approval Details
Approval Id
e660d5414239d820
Drug Cima Aemps Name
BRINZOLAMIDA/BRIMONIDINA ZENTIVA 10 MG/ML+2 MG/ML COLIRIO EN SUSPENSIÓN
Register Number
89824
Holder Company Name
Zentiva K.S.
Marketing Company Name
Zentiva Spain S.L.U.
Holder Company Detail Path
/organization/zentiva-k-s
Authorization Date
2024-09-18
Dosage Form
COLIRIO EN SUSPENSIÓN
Dose
10 mg/ml + 2 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Zentiva K.S.
Company Detail Path
/organization/zentiva-k-s
Company Information
Pharmaceutical Company Name
Zentiva, k.s.
Country Name
Czech Republic
City Name
praha,hlavní město praha,country_cz
Address
U kabelovny 130/22
Active Ingredients
BRINZOLAMIDA
10 mg/ml
BRIMONIDINA TARTRATO
2 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 18, 2024
Approval ID
e660d5414239d820
Type
Standard
Back to CIMA-AEMPS Approvals
BRINZOLAMIDA/BRIMONIDINA ZENTIVA 10 MG/ML+2 MG/ML COLIRIO EN SUSPENSIÓN - CIMA-AEMPS Drug Approval Details